The results obtained indicate that low mTNFα expression levels observed on DCs derived from glioblastoma patients could be attributed not only to the impaired TNFα expression, but also could be caused by high expression and activity levels of TACE/ADAM-17 responsible for shedding mTNFα from the DC membrane. This evidence concerns the gene ADAM17 and glioblastoma.